Research reviewed by Gram suggests that resistance training may help men on hormone therapy for prostate cancer keep muscle and slow bone loss. Bone-protecting medicines remain the main treatment, and exercise and healthy eating appear to add value when combined with them. The authors call for larger, long-term studies to confirm the best plans.

Hormone therapy is a common treatment for prostate cancer, but it can cause men to lose bone and muscle, which raises the risk of falls, fractures, and heart problems. A new review, reported in Supportive Care in Cancer, looked at studies from the last 15 years to see how exercise, nutrition, and medicines might help. According to research reviewed by Gram, resistance training, which means lifting weights or using resistance bands, appears to help men keep lean muscle and may slow bone loss. Researchers also found that bone-protecting medicines remain the main treatment, and that lifestyle changes work best alongside them. The authors suggest that exercise and nutrition should become a standard part of prostate cancer care. They also called for larger, long-term studies to confirm which approaches work best for each person.

Key Statistics

A 2026 narrative review of studies published over the last 15 years found that resistance training appears to help men on hormone therapy for prostate cancer preserve lean body mass and may mitigate bone loss.

A 2026 narrative review in Supportive Care in Cancer concluded that lifestyle measures are an essential component of care alongside bone-protecting medicines for men undergoing hormone therapy, based on evidence from the last 15 years.

The Quick Take

  • What they studied: Can exercise, healthy eating, and medicines help prevent the loss of bone and muscle that often comes with hormone therapy for prostate cancer?
  • Who participated: This is a review of previously published studies rather than a study with its own group of people. The authors looked at research on men with prostate cancer who were receiving hormone therapy. The review does not list a total number of participants.
  • Key finding: Resistance training appears to help men keep muscle and may reduce bone loss, and it also helps with physical strength and movement. The authors noted that bone-protecting medicines are still the main treatment, and lifestyle changes add value on top of them.
  • What it means for you: If you are on hormone therapy for prostate cancer, regular strength training and a diet with enough protein may help protect your bones and muscles. Talk with your cancer care team before starting a new exercise or diet plan, since your needs depend on your health and treatment.

The Research Details

This study is a narrative review, which means the authors read and summarized existing research on a topic instead of running a new experiment. They focused on studies published over the last 15 years that looked at how physical activity, nutrition, or a combination of both affect bone and muscle health in men receiving hormone therapy for prostate cancer.

Because the authors chose which studies to include and how to interpret them, the review is shaped by their judgment. It does not follow a strict set of rules for selecting and combining studies, which is a key feature of a systematic review or meta-analysis. The results are best viewed as an overview of the field rather than a precise measure of effect.

The review also brings together three areas that are often studied separately: exercise, diet, and medicines. This broader view helps explain how these approaches might fit together in real patient care.

A narrative review is useful for seeing the big picture. It helps doctors and patients understand what research has explored so far, which approaches look promising, and where the gaps are. For a topic like bone and muscle loss during cancer treatment, that overview can guide future research and care planning.

However, because the review does not apply strict selection rules, its conclusions are less certain than those from a large pooled analysis of many trials. The findings are best treated as a roadmap for further study rather than final proof that any single approach works.

This review was published in a peer-reviewed journal focused on supportive care in cancer, which means it was checked by other experts before publication. The authors draw on research from the past 15 years, so the evidence reflects recent thinking.

Readers should keep in mind that the review does not report a total number of participants and does not give precise effect sizes. It also does not use a formal scoring system to judge how strong each study was. The authors themselves call for long-term randomized studies to confirm their suggestions, which signals that the evidence base is still developing.

What the Results Show

Hormone therapy, also called androgen deprivation therapy, lowers the level of male hormones in the body. This helps slow prostate cancer, but it can also cause bone to thin and muscle to shrink. Together, these changes are sometimes called osteosarcopenia. The authors explain that this combination raises the risk of falls, broken bones, loss of independence, and heart problems, all of which can affect how men feel and how well they respond to cancer treatment.

The review identifies resistance training as one of the most promising non-pharmacological approaches. Resistance training means working muscles against weight, bands, or body resistance. According to the authors, programs of this type have been shown to help preserve lean body mass, which is the weight of muscle, bone, and organs without fat. They also appear to help limit bone loss and improve physical performance, such as walking speed and balance.

The authors also stress that medicines called antiresorptive agents remain the primary way to protect bones during hormone therapy. These drugs slow the breakdown of bone. The review does not suggest that exercise or diet can replace them. Instead, it presents lifestyle changes as an important addition that works alongside medicine.

Finally, the review concludes that the best care likely combines exercise, nutrition, and medical treatment in a flexible, personalized plan. The authors argue that these steps should be introduced early in treatment rather than only after problems appear.

Beyond bone and muscle, the review points to heart health as an important concern. Hormone therapy has been linked to changes in metabolism, the way the body processes sugar and fat, which can increase cardiovascular risk. Exercise and healthy eating are widely known to support heart and metabolic health, so including them in care may help address these side effects as well.

The authors also raise the idea that good physical function supports quality of life and may even influence how well cancer treatment works. Although the review notes these possibilities, it does not provide strong proof for them, so they should be viewed as areas for future research.

This review fits with a growing body of research showing that exercise is safe and useful for many men receiving prostate cancer treatment. It also matches current medical guidance that bone-protecting medicines are the foundation of care for men on hormone therapy. What this review adds is a clear argument for combining these medicines with structured exercise and nutrition, instead of treating them as separate issues.

The authors note that many current recommendations are still general, and that more detailed, personalized plans are needed. Their call for early integration of lifestyle care into standard treatment reflects a shift in how cancer care teams are thinking about the whole person, not just the tumor.

The biggest limitation is that this is a narrative review rather than a systematic review or meta-analysis. The authors chose which studies to include without a strict, published set of rules, so some relevant research may have been left out, and the selection may reflect the authors’ own views.

The review also does not report the number of participants in the studies it covers, nor does it give exact measurements of how much bone or muscle was preserved. This makes it hard to judge how large the benefits are in everyday terms.

Finally, the authors themselves point out that long-term randomized studies are still needed. Many of the studies discussed may be small or short, which limits how strongly their results can be applied to all men receiving hormone therapy.

The Bottom Line

Research reviewed by Gram suggests that resistance training should be considered a core part of care for men on hormone therapy for prostate cancer, with moderate confidence in its benefits for muscle and physical function. The evidence for bone benefits is less certain, so exercise should be used alongside, not instead of, bone-protecting medicines. Protein-rich eating and staying active are reasonable steps with low risk, though the review does not give a specific diet plan. Confidence is limited by the lack of large, long-term trials.

Men with prostate cancer who are receiving or about to start hormone therapy should find this information useful, especially when discussing their care with a doctor, nurse, or physical therapist. Caregivers, family members, and cancer support teams may also benefit. Men who are not receiving hormone therapy or who have other health conditions should speak with a clinician before changing their routine, since the review does not address every situation.

Muscle strength and physical function may begin to improve within a few weeks to a few months of consistent resistance training, depending on starting fitness and health. Changes in bone density usually take longer to measure, often several months to a year, and they are typically tracked through medical scans. Benefits depend on keeping up the routine over time, so steady habits are more important than quick results.

Frequently Asked Questions

Does exercise help prevent bone loss in men on hormone therapy for prostate cancer?

Exercise appears to help, particularly resistance training, which may slow bone loss in men on hormone therapy. A 2026 review of studies from the last 15 years found that bone-protecting medicines remain the primary treatment, with exercise serving as an important addition rather than a replacement.

What type of exercise is best for muscle loss during prostate cancer hormone therapy?

Resistance training, such as lifting weights, using resistance bands, or doing bodyweight exercises, is the approach the review highlights most. It appears to help preserve lean muscle mass and improve physical performance. Doctors can help tailor a safe program to each person’s health and treatment.

Can diet help protect bones and muscles during hormone therapy for prostate cancer?

The review suggests nutrition is a useful part of a combined plan, but it does not provide a specific diet. Eating enough protein alongside regular strength training may support muscle health. A registered dietitian can recommend a daily protein target based on individual needs and treatment.

Should men with prostate cancer start an exercise plan before or during hormone therapy?

The authors argue that exercise and nutrition should be introduced early in treatment rather than only after problems appear. Starting early may help limit muscle and bone loss. Anyone planning changes should first speak with their oncology team to make sure the activity is safe for them.

Want to Apply This Research?

  • Log resistance training sessions at least three times per week, noting the exercise, number of sets, and number of repetitions. Also track daily protein intake in grams, and record a simple monthly measure such as the number of steps taken or time spent doing a standing balance test.
  • Set a weekly goal of two to three strength sessions of 20 to 30 minutes each, using bands, light weights, or body-weight moves like squats and wall push-ups. Pair each session with a protein-rich meal or snack, and ask a healthcare provider or registered dietitian to help set a daily protein target.
  • Review your logs every month to spot trends in strength, energy, and eating habits. Share these records at medical appointments so your care team can adjust exercise, nutrition, and bone-health monitoring. Plan a check-in every three to six months to revisit goals, especially if your treatment changes.

This article summarizes a narrative review of existing research and is for general information only. It is not medical advice and does not replace guidance from your doctor, oncologist, or other qualified healthcare professional. Do not start, stop, or change any exercise program, diet, or medicine without first speaking with your care team, especially if you are receiving cancer treatment.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Multimodal lifestyle strategies for ADT-induced osteosarcopenia and metabolic dysfunction in prostate cancer. , Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2026). PubMed 43064850 | DOI
Topics
prostate cancer hormone therapy bone loss muscle loss resistance training osteosarcopenia prostate cancer exercise cancer nutrition